WESTPORT, CT (Reuters Health) - Epidemiological evidence suggests that the HIV-1 epidemic in homosexuals and intravenous drug users in Western countries originated from different sources.
Dr. Carla Kuiken from Los Alamos National Laboratory in Los Alamos, New Mexico, and colleagues analyzed the relationship of various HIV-1 variants within subtype B (the most prevalent subtype in Western countries) in homosexuals and intravenous drug users in Sweden, Norway and Holland in an effort to understand how the epidemic might have spread.
In both Sweden and Norway, the two risk groups carried distinct HIV-1 variants, the authors report in the November issue of the American Journal of Epidemiology. Moreover, the mutations shared by Swedish and Dutch drug users were common, whereas those unique to each country were relatively rare.
Similarly, the sequences from Norwegian and Dutch homosexuals seemed to be indistinguishable, the researchers note.
"Differences between homosexual and intravenous drug user virus populations appear to be ubiquitous in Northern Europe," the authors conclude. "Based on the available data, the most plausible scenario seems to be that the subtype B virus was carried out of Africa and introduced into the Western homosexual community by one person."
The researchers postulate that the virus then spread to other risk groups in the U.S., where the virus evolved independently, remaining relatively homogeneous within the separate risk groups.
"Sequencing of more virus variants from a large number of U.S. intravenous drug users from different geographic locations would seem to be the best way to determine the plausibility of this scenario," they assert.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.